Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria
3-hydroxy-3-methylglutaric aciduria (HMGA; OMIM 246450) is a rare autosomal recessive disorder, caused by the deficiency of 3-hydroxy-3-methylglutaryl-CoA lyase (18.104.22.168), which results in the accumulation of 3-hydroxy-3-methylglutaric (HMG) and 3-methylglutaric (MGA) acids in tissues and biological fluids of affected individuals. Recent in vivo and in vitro animal studies have demonstrated that the accumulation of these metabolites can disturb the cellular redox homeostasis, which can contribute to the neurological manifestations presented by the patients. So, in the present work, we investigated oxidative stress parameters in plasma and urine samples from HMGA patients, obtained at the moment of diagnosis of this disorder and during therapy with low-protein diet and L-carnitine supplementation. It was verified that untreated HMGA patients presented higher levels of urinary di-tyrosine and plasma thiobarbituric acid-reactive substances (TBA-RS), which are markers of protein and lipid oxidative damage, respectively, as well as a reduction of the urinary antioxidant capacity. Treated HMGA patients also presented an increased protein oxidative damage, as demonstrated by their higher concentrations of plasma protein carbonyl groups and urinary di-tyrosine, as well as by the reduction of total sulfhydryl groups in plasma, in relation to controls. On the other hand, HMGA patients under therapy presented normal levels of TBA-RS and urinary antioxidant capacity, which can be related, at least in part, to the antioxidant and antiperoxidative effects exerted by L-carnitine. The results of this work are the first report showing that a redox imbalance occurs in patients with HMGA what reinforces the importance of the antioxidant therapy in this disorder.
Keywords3-hydroxy-3-methylglutaric aciduria Organic acidurias Carnitine Oxidative stress Oxidative damage
The authors are grateful to the patients, their families, and the physicians of the patients. This work was supported in part by grants from CNPq, FAPERGS, and FIPE/HCPA-Brazil.
Conflict of interest
The authors declare that there is no conflict of interest.
- 3.Chalmers RA, Lawson AM (1982) Organic acids in man. Analytical chemistry, biochemistry and diagnosis of the organic acidurias. Chapman and Hall, LondonGoogle Scholar
- 5.Wajner M, Coelho DM, Ingrassia R, de Oliveira AB, Busanello EN, Raymond K, Flores Pires R, de Souza CF, Giugliani R, Vargas CR (2009) Selective screening for organic acidemias by urine organic acid GC-MS analysis in Brazil: fifteen-year experience. Clin Chim Acta 400:77–81CrossRefPubMedGoogle Scholar
- 6.Vargas CR, Sitta A, Schmitt G, Ferreira GC, Cardoso ML, Coelho D, Gibson KM, Wajner M (2007) Incidence of 3-hydroxy-3-methylglutaryl-coenzyme A lyase (HL) deficiency in Brazil, South America, J Inherit Metab Dis pp. 1–5Google Scholar
- 7.Sweetman L, Williams JC (2001) Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) Metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1387–1422Google Scholar
- 12.Lyon G, Adams RD, Kolodny EH (1996) The neurology of neonatal hereditary metabolic diseases. In: Lyon G (ed) Neurology of hereditary metabolic diseases of children. Mc Graw-Hill, New York, pp 6–44Google Scholar
- 17.Fernandes CG, da Rosa MS, Seminotti B, Pierozan P, Martell RW, Lagranha VL, Busanello EN, Leipnitz G, Wajner M (2013) In vivo experimental evidence that the major metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency induce oxidative stress in striatum of developing rats: a potential pathophysiological mechanism of striatal damage in this disorder. Mol Genet Metab 109:144–153CrossRefPubMedGoogle Scholar
- 18.Leipnitz G, Seminotti B, Haubrich J, Dalcin MB, Dalcin KB, Solano A, de Bortoli G, Rosa RB, Amaral AU, Dutra-Filho CS, Latini A, Wajner M (2008) Evidence that 3-hydroxy-3-methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex. J Neurosci Res 86:683–693CrossRefPubMedGoogle Scholar
- 19.Leipnitz G, Seminotti B, Fernandes CG, Amaral AU, Beskow AP, da Silva Lde B, Zanatta A, Ribeiro CA, Vargas CR, Wajner M (2009) Striatum is more vulnerable to oxidative damage induced by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency as compared to liver. Int J Dev Neurosci 27:351–356CrossRefPubMedGoogle Scholar
- 25.Sweetman L (1991) Organic acid analysis. In: Hommes FA (ed) Techniques in diagnostic human biochemical genetics. Wiley-Liss, New York, pp 143–176Google Scholar
- 28.Ribas GS, Manfredini V, de Mari JF, Wayhs CY, Vanzin CS, Biancini GB, Sitta A, Deon M, Wajner M, Vargas CR (2010) Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation. Int J Dev Neurosci 28:127–132CrossRefPubMedGoogle Scholar
- 34.da Rosa MS, Seminotti B, Amaral AU, Fernandes CG, Gasparotto J, Moreira JC, Gelain DP, Wajner M, Leipnitz G (2013) Redox homeostasis is compromised in vivo by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in rat cerebral cortex and liver. Free Radic Res 47:1066–1075CrossRefPubMedGoogle Scholar
- 36.Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Claredon Press, OxfordGoogle Scholar
- 48.Sitta A, Vanzin CS, Biancini GB, Manfredini V, de Oliveira AB, Wayhs CA, Ribas GO, Giugliani L, Schwartz IV, Bohrer D, Garcia SC, Wajner M, Vargas CR (2011) Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31:429–436CrossRefPubMedGoogle Scholar